{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:09:12Z","timestamp":1789834152952,"version":"4.0.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Comput Assist Tomogr"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Glioblastoma represents the most common primary brain malignancy with a median survival of 15 months. Follow-up examinations are crucial to establish the presence of tumor recurrence, as well as treatment-associated changes such as ischemic infarction and radiation effects. Even though magnetic resonance imaging is a valuable tool, a histopathological diagnosis is often required because of imaging overlap between tumor recurrence and treatment associated changes. We set out to measure the apparent diffusion coefficient (ADC) values of the lesions in magnetic resonance imaging scans of treated glioblastoma patients to investigate if ADC values could accurately differentiate between tumor progression, radiation-related changes, and ischemic infarctions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We evaluated ADC values among 3 groups, patients with tumor progression, radiation necrosis, and ischemic infarctions. The regions of interest were placed in the areas of greatest hypointensity among solid lesions using the ADC maps, excluding areas with necrotic, cystic, or hemorrhagic changes. The ADC values of the contralateral normal appearing white matter were also measured as the reference value for each patient. The relative ADC (rADC) values were measured for all 3 groups. Comparison between lesions and normal white matter was evaluated by Wilcoxon signed test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 157 patients were included in the study; 49 patients classified as tumor progression, 58 patients as radiation necrosis, and 50 patients as ischemic infarctions. The mean \u00b1 SD ADC value was 752.8 \u00b1 132.5 for tumor progression, 479.0 \u00b1 105.2 for radiation-related changes, and 250.1 \u00b1 57.2 for ischemic infarctions. The mean \u00b1 SD rADC value was 1.07 \u00b1 0.22 for tumor progression, 0.66 \u00b1 0.14 for radiation necrosis, and 0.34 \u00b1 0.08 for ischemic infarctions. The mean rADC values were significantly higher in tumor progression, compared with both radiation necrosis and ischemic changes (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The present study demonstrates that ADC values are a helpful tool to differentiate between tumor progression, radiation necrosis, and posttreatment ischemic changes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rct.0000000000001373","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T10:21:09Z","timestamp":1663323669000},"page":"923-928","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["The Role of Apparent Diffusion Coefficient Values in Glioblastoma: Differentiating Tumor Progression Versus Treatment-Related Changes"],"prefix":"10.1097","volume":"46","author":[{"given":"Arash","family":"Kamali","sequence":"first","affiliation":[{"name":"Neuroradiology Section, Department of Diagnostic and Interventional Radiology, University of Texas at Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis C.","family":"Nunez","sequence":"additional","affiliation":[{"name":"Neuroradiology Section, Department of Diagnostic and Interventional Radiology, University of Texas at Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E.","family":"Lugo","sequence":"additional","affiliation":[{"name":"McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Arevalo-Espejo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Louisiana State University, Shreveport, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay-Jiguang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshua","family":"Esquenazi-Levy","sequence":"additional","affiliation":[{"name":"Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neuroradiology Section, Department of Diagnostic and Interventional Radiology, University of Texas at Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy F.","family":"Riascos","sequence":"additional","affiliation":[{"name":"Neuroradiology Section, Department of Diagnostic and Interventional Radiology, University of Texas at Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"key":"bib1-20250802","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","year":"2015","journal-title":"Pharmacol Ther"},{"key":"bib3-20250802","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/ajco.12756","article-title":"Biomarkers and therapeutic advances in glioblastoma multiforme","volume":"14","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"bib4-20250802","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjmed.2017.12.039","article-title":"Brain tumors","volume":"131","year":"2018","journal-title":"Am J Med"},{"key":"bib5-20250802","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.ctrv.2019.101896","article-title":"Molecular targeted therapy of glioblastoma","volume":"80","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"bib6-20250802","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"bib7-20250802","first-page":"1455","article-title":"Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence","volume":"26","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib8-20250802","first-page":"81","article-title":"Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy","volume":"48","year":"2010","journal-title":"Folia Neuropathol"},{"key":"bib9-20250802","first-page":"201","article-title":"Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury","volume":"25","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.acra.2015.11.015","article-title":"Comparison of diffusion tensor imaging and magnetic resonance perfusion imaging in differentiating recurrent brain neoplasm from radiation necrosis","volume":"23","year":"2016","journal-title":"Acad Radiol"},{"key":"bib11-20250802","first-page":"18","article-title":"Multiparametric MRI for differentiation of radiation necrosis from recurrent tumor in patients with treated glioblastoma","volume":"210","year":"2017","journal-title":"Am J Roentgenol"},{"key":"bib12-20250802","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clinimag.2017.06.009","article-title":"Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging","volume":"46","year":"2017","journal-title":"Clin Imaging"},{"key":"bib13-20250802","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.mri.2006.07.008","article-title":"Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions","volume":"24","year":"2006","journal-title":"Magn Reson Imaging"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00234-010-0731-4","article-title":"Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging","volume":"52","year":"2010","journal-title":"Neuroradiology"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3174\/ajnr.A5485","article-title":"Diagnostic accuracy of centrally restricted diffusion in the differentiation of treatment-related necrosis from tumor recurrence in high-grade gliomas","volume":"39","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijrobp.2006.12.001","article-title":"Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging","volume":"68","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib17-20250802","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11912-019-0818-y","article-title":"Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities","volume":"21","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"bib18-20250802","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.rcl.2019.07.003","article-title":"Imaging glioblastoma posttreatment","volume":"57","year":"2019","journal-title":"Radiol Clin North Am"},{"key":"bib19-20250802","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/COC.0b013e31829c3139","article-title":"Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience","volume":"38","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"bib20-20250802","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2176\/nmc.ra.2014-0188","article-title":"Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain","volume":"55","year":"2015","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"bib21-20250802","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12943-019-0950-1","article-title":"Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues","volume":"18","year":"2019","journal-title":"Mol Cancer"},{"key":"bib22-20250802","doi-asserted-by":"crossref","first-page":"61945","DOI":"10.18632\/oncotarget.11482","article-title":"Infarct volume after glioblastoma surgery as an independent prognostic factor","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00004728-200309000-00003","article-title":"Diffusion-weighted magnetic resonance imaging in radiation-induced cerebral necrosis. Apparent diffusion coefficient in lesion components","volume":"27","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"bib24-20250802","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0895-6111(00)00083-5","article-title":"Diffusion MRI: apparent diffusion coefficient (ADC) values in the normal brain and a classification of brain disorders based on ADC values","volume":"25","year":"2001","journal-title":"Comput Med Imaging Graph"},{"key":"bib25-20250802","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1148\/rg.2018170115","article-title":"Introduction to the technical aspects of computed diffusion-weighted imaging for radiologists","volume":"38","year":"2018","journal-title":"Radiographics"},{"key":"bib26-20250802","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/CPJ.0b013e318278bee1","article-title":"Diagnostic approach to restricted-diffusion patterns on MR imaging","volume":"2","year":"2012","journal-title":"Neurol Clin Pract"},{"key":"bib27-20250802","first-page":"1310","article-title":"Diffusion-weighted imaging in the assessment of brain abscesses therapy","volume":"25","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib28-20250802","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/mrm.20645","article-title":"Biological correlates of diffusivity in brain abscess","volume":"54","year":"2005","journal-title":"Magn Reson Med"},{"key":"bib29-20250802","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0730-725X(96)00237-8","article-title":"Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging","volume":"14","year":"1996","journal-title":"Magn Reson Imaging"},{"key":"bib30-20250802","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejrad.2019.05.021","article-title":"Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors","volume":"117","year":"2019","journal-title":"Eur J Radiol"},{"key":"bib31-20250802","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1148\/rg.343135047","article-title":"Diffusion-weighted imaging in pediatric body MR imaging: principles, technique, and emerging applications","volume":"34","year":"2014","journal-title":"Radiographics"},{"key":"bib32-20250802","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/annonc\/mdz164","article-title":"Molecular pathology of tumors of the central nervous system","volume":"30","year":"2019","journal-title":"Ann Oncol"},{"key":"bib33-20250802","article-title":"Use of quantitative diffusion-weighted MR imaging (DWI) in differentiating between glioblastoma and primary central nervous system lymphoma in real-time exam interpretation","year":"2019","journal-title":"Neurol Neurosurg [Internet]"},{"key":"bib34-20250802","doi-asserted-by":"crossref","first-page":"18148","DOI":"10.18632\/oncotarget.24454","article-title":"The value of whole lesion ADC histogram profiling to differentiate between morphologically indistinguishable ring enhancing lesions-comparison of glioblastomas and brain abscesses","volume":"9","year":"2018","journal-title":"Oncotarget"},{"key":"bib35-20250802","first-page":"9","article-title":"2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation","volume":"82\u201383","year":"2020","journal-title":"Nucl Med Biol"},{"key":"bib36-20250802","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11547-018-0866-7","article-title":"Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2","volume":"123","year":"2018","journal-title":"Radiol Med"},{"key":"bib37-20250802","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1038\/s41598-021-82467-y","article-title":"Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation","volume":"11","year":"2021","journal-title":"Sci Rep"},{"key":"bib38-20250802","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1148\/radiol.2017161588","article-title":"Differentiation of recurrent glioblastoma from delayed radiation necrosis by using voxel-based multiparametric analysis of MR imaging data","volume":"285","year":"2017","journal-title":"Radiology"},{"key":"bib39-20250802","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1634\/theoncologist.2020-0085","article-title":"Defining treatment-related adverse effects in patients with glioma: distinctive features of pseudoprogression and treatment-induced necrosis","volume":"25","year":"2020","journal-title":"Oncologist"},{"key":"bib40-20250802","first-page":"6828396","article-title":"Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas","volume":"2018","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"bib41-20250802","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.acra.2012.06.011","article-title":"Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas","volume":"19","year":"2012","journal-title":"Acad Radiol"},{"key":"bib42-20250802","doi-asserted-by":"crossref","first-page":"e0174620","DOI":"10.1371\/journal.pone.0174620","article-title":"Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps","volume":"12","year":"2017","journal-title":"PloS One"},{"key":"bib43-20250802","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2214\/AJR.16.16234","article-title":"Predicting glioblastoma recurrence by early changes in the apparent diffusion coefficient value and signal intensity on FLAIR images","volume":"208","year":"2017","journal-title":"Am J Roentgenol"},{"key":"bib44-20250802","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2342-11-2","article-title":"The use of MRI apparent diffusion coefficient (ADC) in monitoring the development of brain infarction","volume":"11","year":"2011","journal-title":"BMC Med Imaging"},{"key":"bib45-20250802","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12035-018-1073-1","article-title":"Early detection of cerebral infarction after focal ischemia using a new MRI indicator","volume":"56","year":"2019","journal-title":"Mol Neurobiol"},{"key":"bib46-20250802","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.12659\/MSM.897149","article-title":"Prognostic value of diffusion-weighted imaging (DWI) apparent diffusion coefficient (ADC) in patients with hyperacute cerebral infarction receiving rt-PA intravenous thrombolytic therapy","volume":"22","year":"2016","journal-title":"Med Sci Monit"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T23:16:41Z","timestamp":1754176601000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001373","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,3]]}}}